POSTER SESSION IV
Tuesday, March 27, 2007 — 1:00 PM - 4:30 PM
Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
HEMATOPATHOLOGY
Poster#
Title and Authors
Itinerary Planner
138
Infant Acute Lymphoblastic Leukemia: A 20 Year Children’s Hospital Experience
(1159)
RAF Murray, G Thom, R Gardner, RD Craver - Louisiana State University Health Science Center, New Orleans, LA
How To Distinguish Precursor T-Cell Lymphoblastic Lymphoma from Lymphocyte-Rich Subtypes of Thymomas: A Role for Immunohistochemistry?
(1088)
B Coleman, M Czader, EE Torlakovic, J Henley, A Orazi - Indiana University, Indianapolis, IN; Royal University Hospital, Saskatoon, SK, Canada
Precursor Lymphoblastic Leukemia: Immunophenotype Comparison between Children and Adults
(1103)
G Gheorghe, T Sun, CH Dunphy, P Lin, A Gupta, X Liang - University of Colorado Health Science Center, Denver, CO; VA Medical Center, Denver, CO; University of North Carolina at Chapel Hill, Chapel Hill, NC; University of Texas, M.D. Anderson Cancer Center, Huston, TX; The Children’s Hospital, Denver, CO
Secondary Acute Lymphoblastic Leukemia. A Single Institution Experience and Review of the Literature
(1192)
FA Shakil, RS Stein, A Yenamandra, TL McCurley - Vanderbilt University School of Medicine, Nashville, TN; Genetics Associates, Nashville, TN
Pediatric CD117 Positive Precursor T Lymphoblastic Leukemia/Lymphoblastic Lymphoma Is Not Exclusively of Pro T-Cell Immunophenotype
(1150)
S Lott, A Orazi, M Czader - Ball Memorial Hospital, Muncie, IN; Indiana University, Indianapolis, IN
CD81 Is Aberrantly Underexpressed by Most Precursor B-Cell Acute Lymphoblastic Leukemias: Implications for Flow Cytometric Minimal Residual Disease Assays
(1131)
JL Jorgensen, A Brahmandam, DA Thomas - UT MD Anderson Cancer Center, Houston, TX; UTMDACC
Molecular Detection of Residual Leukemic Cells by a Novel DNA Methylation Biomarker
(1206)
MX Wang, HD Shi, XH Zhao, KH Taylor, D Duff, CW Caldwell - University of Missouri School of Medicine and Ellis Fischel Cancer Center, Columbia, MO; University of California at Irvin Medical Center, Orange, CA
Acute Myeloid Leukemias with a CD34(-)/HLA-DR(-) Immunophenotype Encompass a Wide Range of Morphologic Subtypes
(1205)
HY Wang, Y Xu, RW McKenna, NJ Karandikar, J Doolittle - UT Southwestern Medical Center, Dallas, TX; Carlsbad, CA
The Morphological Subcategories of Acute Monocytic Leukemia (M5a and M5b) Share Similar Immunophenotypic and Cytogenetic Features and Clinical Outcomes
(1202)
P Villeneuve, J Brandwein, H Chang - University Health Network and Dept of Lab Medicine & Pathobiology, University of Toronto, Toronto, ON, Canada
Nuclear Factor Kappa B Is Overexpressed in Acute Myeloid Leukemia with inv(16)(p13q22) Compared with Acute Myelomonocytic Leukemia (M4) without inv16
(1137)
S Konoplev, X Sun, HM Kantarjian, EH Estey, LJ Medeiros, CE Bueso-Ramos - MD Anderson Cancer Center, Houston, TX
Growth Factor Receptor Expression in Acute Myeloid Leukemia: Prognostic Implications of CD114 and CD116
(1076)
M Bodnar, CO Kelly, A Beri, R Sutherland, H Chang - University Health Network, Toronto, Canada; University of Toronto, Toronto, Canada
Therapy-Related Acute Myeloid Leukemia Associated with t(8;21)(q22;q22). A Study of 8 Patients
(1110)
SA Gustafson, P Lin, L Chen, LV Abruzzo, LJ Medeiros - The University of Texas M.D. Anderson Cancer Center, Houston, TX
The JAK2 V617F Mutation Is Not Identified in Hematological Malignancies Associated with Bone Marrow Fibrosis Other Than Chronic Myeloproliferative Disorders
(1166)
RJ Olsen, CV Curry, AL Vanguri, CH Dunphy, CC Chang - The Methodist Hospital, Houston, TX; University of Texas, Austin, TX; University of North Carolina, Chapel Hill, NC
The JAK2 V617F Mutation Is Rare in Reactive Lymphoid Infiltrates of Chronic Myeloproliferative Disorders (cMPD) and Absent in Concomitant Non-Hodgkin Lymphomas (NHL)
(1141)
M Kremer, T Horn, C Peschel, S Gattenloehner, L Quintanilla-Martinez, F Fend - Technical University of Munich, Munich, Germany; University of Wuerzburg, Wuerzburg, Germany; GSF-Research Center, Neuherberg, Germany
Detection of JAK2 Kinase Mutations in Formalin-Fixed Spleen, a Comparison of Two Molecular Assays
(1102)
TI George, K Seo, S Blais, DA Arber - Stanford University, Stanford, CA
MPL W515L Is Uncommon in Myeloproliferative Diseases but Is Associated with Abnormal STAT5 Activation Similar to That Seen with JAK2 V617F
(1188)
AE Schade, H Szpurka, B Bak, JP Maciejewski, ED Hsi - Cleveland Clinic, Cleveland, OH
Chronic Myelogenous Leukemia with Deletions of der(9) Is Morphologically Similar to CML without Deletions
(1169)
A Orazi, M Czader, GH Vance - Indiana University School of Medicine, Indianapolis, IN
Novel, Alternatively Spliced BCRABL Transcripts in Chronic Myeloid Leukemia
(1148)
J Lin, HC Weigelin, JK Howard, JA Thorson - University of Michigan, Ann Arbor, MI
Myeloproliferative Disorders and Myelodysplastic Syndromes Have Different Degrees of p38 MAPK Activation
(1191)
M Shahjahan, CH Dunphy, L Garza, L Novoa-Takara, Y Zu, C Chang - The Methodist Hospital, Houston, TX; University of North Carolina, Chapel Hill, NC; Medical College of Wisconsin, Milwaukee, WI
Mast Cell Nuclear Phospho-STAT5 Expression in Systemic Mastocytosis: A Diagnostically Useful Phenotypic Abnormality That Reflects Underlying Biologic Alterations
(1224)
T Zuluaga Toro, F Hsieh, H Dong, ED Hsi - Cleveland Clinic, Cleveland, OH; Genzyme Genetics, New York, NY
An Evaluation of Mast Cells Subsets Using Computed Image Analysis in the Myeloproliferative Disorders (MPD) and Myelodysplastic Syndromes (MDS) and a Correlation with Marrow Fibrosis
(1172)
MP Powers, A Ahmed, CH Dunphy, KA Youker, Y Zu, CC Chang - The Methodist Hospital and TMHRI, Houston, TX; Roswell Park, Buffalo, NY; University of North Carolina, Chapel Hill, NC; TMHRI, Houston, TX; Weill Cornell College of Medicine, Houston, TX
button next to any title to add to Itinerary Planner...
Add
